Narayana Hrudayalaya Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,844 Cr +73% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
NH

Narayana Hrudayalaya Ltd

Q2 FY26Healthcare Services

Narayana Hrudayalaya Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,644Cr
+20.3% YoY
+9.1% QoQ
Net profit
₹258Cr
+29.6% YoY
+31% QoQ
Margin
24%
+1 pp YoY
+2 pp QoQ
Price₹1,816
Market cap₹38.9K Cr
P/E45.1

The short version

Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. EBITDA growth driven by volume pick-up through better payor-mix with more high-paying payors, not just pricing increases (low single-digit pricing hikes annually).

From Narayana Hrudayalaya Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. (Page 25)
  • Volumes are currently stabilizing; from next two quarters onwards, positive volume growth alongside improved realizations due to better payor-mix is anticipated. (Page 15)
  • Incremental revenue growth is attributed to better paying payors, efficiency improvements, throughput enhancement, and increase in high-order procedures rather than pricing hikes. (Page 25)
  • Cayman hospital revenue saw significant growth post-commissioning of new hospital, with approximately 50% increase in discharges and outpatient/daycare volumes; further growth expected for a few more quarters before moderating to high single-digit growth. (Pages 4, 15)
  • Insurance business growth in Cayman is early-stage with strong sales pipeline and increasing employer interest, but underwriting results will stabilize only over multiple quarters; room for considerable growth remains. (Pages 12, 15)

2 more points from Narayana Hrudayalaya Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Narayana Hrudayalaya Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Planned CapEx guidance for FY26 and FY27: Detailed guidance for FY27 will be provided closer to year-end.
  • Over the next three years, a total of about INR 3,000 crores CapEx is planned in India, covering Greenfield, Brownfield, Operations & Maintenance, and acquisitions.
  • Spend breakup and project status for individual hospitals are available in the investor slides.
  • Some spillover of CapEx timing expected, with cash outflows possibly extending slightly beyond fiscal year boundaries.
  • Investments include setting up new hospitals (e.g., 100-bed hospital in Bangalore expected by Q1 FY26).

2 more points from Narayana Hrudayalaya Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Narayana Hrudayalaya Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Narayana Hrudayalaya Ltd said on order book & pipeline — free account, 30 seconds.

Narayana Hrudayalaya Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Narayana Hrudayalaya Ltd Q2 FY26 results — key figures

Narayana Hrudayalaya Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue1,6441,367+20.3%1,507+9.1%
Operating profit (EBITDA)401309+29.8%337+19%
Operating margin24%23%+1 pp22%+2 pp
Profit before tax296232+27.6%232+27.6%
Net profit (PAT)258199+29.6%197+31%
EPS (₹)12.649.72+30%9.62+31.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.8K Cr, net profit ₹301 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Maitreya Medicare (Q2 FY26)

    23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.

  • Metropolis Healt (Q2 FY26)

    Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…

  • 3B Blackbio (Q2 FY26)

    Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…

  • Unihealth Hosp (Q2 FY26)

    Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Narayana Hrudayalaya Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Narayana Hrudayalaya Ltd Q2 FY26 results?

Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. EBITDA growth driven by volume pick-up through better payor-mix with more high-paying payors, not just pricing increases (low single-digit pricing hikes annually).

What is Narayana Hrudayalaya Ltd share price analysis?

Narayana Hrudayalaya Ltd currently shows a neutral. The stock trades at a P/E of 45.1 with a market cap of ₹38,892 Cr. Investors should review the full earnings analysis for detailed insights.

Is Narayana Hrudayalaya Ltd planning capital expenditure?

Planned CapEx guidance for FY26 and FY27: Detailed guidance for FY27 will be provided closer to year-end.

Keep Narayana Hrudayalaya Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.